Quantessence Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Quantessence Capital's REGN Position: Q3 2026 in Review
Quantessence Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 440 shares worth $334K. The stake represents 1.67% of the portfolio and ranks #26 among its holdings.
1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Quantessence Capital held 440 shares of Regeneron Pharmaceuticals worth $334K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Quantessence Capital position in Q3 2026.
- Regeneron Pharmaceuticals made up 1.67% of Quantessence Capital's portfolio in Q3 2026, its #26 holding.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Quantessence Capital's 13F filing for Q3 2026, filed 16 Nov 2026.